Sustained release emphasizing recombinant human bone morphogenetic protein-2

Advanced Drug Delivery Reviews

Volumn 31, Issue 3, 1998, Pages 303-318

  Winn, Shelley R ^a   Uludag, Hasan ^b   Hollinger, Jeffrey O ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b PFIZER INC   (United States)

Author keywords

Bone regeneration; Collagen; Growth factors; Osteoconduction; Osteoinduction; Poly( hydroxy acids); RhBMP 2; TGF superfamily; Tissue engineering

Indexed keywords

BONE; CLONING; COLLAGEN; HORMONES; ORGANIC ACIDS; PROTEINS;

OSTEOCONDUCTION; OSTEOINDUCTION; POLYHYDROXY ACIDS;

CONTROLLED DRUG DELIVERY;

BIOMATERIAL; BONE MORPHOGENETIC PROTEIN; COLLAGEN; DRUG CARRIER; HYDROXYACID; POLYLACTIC ACID; POLYMER; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN 2; UNCLASSIFIED DRUG;

ARTICLE; BIOENGINEERING; BONE MATRIX; BONE REGENERATION; DRUG DELIVERY SYSTEM; NONHUMAN; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION;

EID: 0032482163     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-409X(97)00126-9     Document Type: Review

References (133)

1. D.J. Prolo, J.J. Rodrigo, Contemporary bone graft physiology and surgery, Clin. Orthop. Relat. Res. 200 (1985) 322-342.
2. A.J. Yaszemski, R.G. Payne, W.C. Hayes, R. Langer, A.G. Mikos, Evolution of bone transplantation: Molecular, cellular and tissue strategies to engineer human bone, Biomaterials 17 (1996) 175-185.
3. J. Lane, H. Sandhu, Current approaches to experimental bone grafting, Orthop. Clin. North Am. 18 (1987) 213-225.
4. C.F. Gregory, The current status of bone and joint transplants, Clin. Orthop. Relat. Res. 87 (1972) 156-166.
5. W.F. Enneking, E.R. Mindell, Observations on massive retrieved human allografts, J. Bone Jt. Surg. Ser. A 73 (1991) 1123-1142.
6. B.E. Buck, T.I. Malinin, Bone transplantation and human immunodeficiency virus. An estimate of risk of acquired immunodeficiency syndrome (AIDS), Clin. Orthop. Relat. Res. 240 (1989) 129-136.
7. B.E. Buck, L. Resnick, S.M. Shah, Human immunodeficiency virus cultured from human bone, Clin. Orthop. Relat. Res. 251 (1990) 249-252.
8. F. DeLustro, J. Dasch, J. Keefe, L. Ellingsworth, Immune responses to allogeneic and xenogeneic implants of collagen and collagen derivatives, Clin. Orthop. Relat. Res. 260 (1990) 263-279.
9. M.C. Horowitz, G.E. Friedlaender, Induction of specific T-cell responsiveness to allogeneic bone, J. Bone Jt. Surg. Ser. A 73 (1991) 1157-1168.
10. B. McKibbin, The biology of fracture healing in long bones, J. Bone Jt. Surg. 60 (1978) 150-162.
11. C. Brighton, Principles of fracture healing. Part I: The biology of fracture repair, Instructional Course, 32, 1984, p. 60.
12. D.J. Simmons, Fracture healing perspectives, Clin. Orthop. Relat. Res. 200 (1985) 100-113.
13. C.T. Brighton, R.M. Hunt, Early histological and ultrastructural changes in medullary fracture callus, J. Bone Jt. Surg. Ser. A 73 (1991) 832-847.
14. M.E. Bolander, Regulation of fracture repair by growth factors, Proc. Soc. Exp. Biol. Med. 200 (1992) 165-170.
15. A.H. Reddi, Extracellular matrix and development, in: K.A. Piez, A.H. Reddi (Eds.), Extracellular Matrix Biochemistry, Elsevier, New York, 1984, pp. 375-412.
16. S. Vukicevic, V.M. Paralkar, A.H. Reddi, Extracellular matrix and bone morphogenetic proteins in cartilage and bone development and repair, Adv. Mol. Cell Biol. 6 (1993) 207-224.
17. A.H. Reddi, Bone matrix in the solid state: Geometric influence on differentiation of fibroblasts, Adv. Biol. Med. Phys. 15 (1974) 1-15.
18. G. Levander, A study of bone regeneration, Surg. Gynecol. Obstet. 67 (1938) 705-714.
19. M.R. Urist, Bone: Formation by autoinduction, Science 150 (1965) 893-899.
20. M.R. Urist, M.F. Silverman, K. Buring, F.L. Dubuc, J.M. Rosenburg, The bone induction principle, Clin. Orthop. Relat. Res. 53 (1967) 243.
21. M.R. Urist, B.S. Strates, Bone morphogenetic protein, J. Dent. Res. 50 (1971) 1392-1406.
22. D.M. Kingsley, The TGF-beta superfamily: New members, new receptors, and new genetic tests of function in different organisms, Genes Dev. 8 (1994) 133-146.
23. A. Yamaguchi, Regulation of differentiation pathway of skeletal mesenchymal cells in cell lines by transforming growth factor-β superfamily, Cell Biol. 6 (1995) 165-173.
24. J. Wozney, Bone morphogenetic proteins and their gene expression, in: Cellular and Molecular Biology of Bone, Academic Press, New York, 1993, pp. 131-167.
25. K. Elima, Osteoinductive proteins, Ann. Med. 25 (1993) 395-402.
26. J.M. Wozney, Bone morphogenetic proteins, Prog. Growth Factors 1 (1989) 267-280.
27. J.M. Wozney, The bone morphogenetic protein family and osteogenesis, Mol. Reprod. Dev. 32 (1992) 160-167.
28. J.M. Wozney, V. Rosen, A.J. Celeste, L.M. Mitsock, M.J. Whittiers, R.W Kriz, R.M. Hewick, E.A. Wang, Novel regulators of bone formation: Molecular clones and activities, Science 242 (1988) 1528-1534.
29. J.L. Dube, A.J. Celeste, Human bone morphogenetic protein-15: A new member of the transforming growth factor-β superfamily, Trans. ASBMR 18 (1996) S382.
30. E.A. Wang, V. Rosen, P. Cordes, R.M. Hewick, M.J. Kriz, D. Luxenberg, B. Sibley, J. Wozney, Purification and characterization of other distinct bone inducing factors, Proc. Natl. Acad. Sci. USA 85 (1988) 9484-9488.
31. A.J. Celeste, R. Taylor, N. Yamaji, E. Wang, J. Ross, J. Wozney, Molecular cloning of BMP-8: Present in bovine bone which is highly related to BMP-5/6/7 subfamily of osteoinductive molecules, Keystone Symposium, 16F, 1992, p. 100.
32. M. Inada, T. Katagiri, S. Akiyama, M. Namiki, M. Komaki, A. Yamaguchi, K. Kamoi, V. Rosen, T. Suda, Bone morphogenetic protein-12 and -13 inhibit terminal differentiation of myoblasts, but do not induce their differentiation into osteoblasts, Biochem. Biophys. Res. Commun. 222 (1996) 317-322.
33. A.J. Celeste, A.J. Ross, N. Yamaji, J.M. Wozney, The molecular cloning of human bone morphogenetic proteins-10 -11, and -12, three new members of the transforming growth factor-beta superfamily, J. Bone Miner. Res. 10(1S) (1995) 334-339.
34. J.L. Dube, A.J. Celeste, Human bone morphogenetic protein-13, a molecule which is highly related to human bone morphogenetic protein-12, J. Bone Miner. Res. 10 (1995) 333-339.
35. J.O. Hollinger, D. Buck, S. Brader, Biology of bone healing: Its impact on clinical therapy, in: S. Lynch (Ed.), Tissue Engineering in Dentistry, Quintessence, San Diego, CA (in press).
36. D. Kingsley, What do BMPs do in mammals? Clues from the mouse short-ear mutation, TIG 10 (1994) 16-21.
37. M.R. Urist, The search for and discovery of bone morphogenetic protein, in: M.R. Urist, B.T. O'Conner, R.G. Burwell (Eds), Bone Grafts, Derivatives and Substitutes, Butterworth, London, 1994, pp. 315-362.
38. J.A. Buckwalter, M.J. Glimcher, R.R. Cooper, R. Recker, Bone Biology. I. Structure, blood supply, cells, matrix and mineralization, J. Bone Jt. Surg. 77 (1995) 1256-1275.
39. W. Rousch, Hedgehog's patterning call is patched through, smoothly, Science 274 (1996) 1304.
40. M.A. Haralson, Extracellular matrix and growth factors: An integrated interplay controlling tissue repair and progression to disease, Lab Invest. 69 (1993) 369-372.
41. P.V. Hauschka, A.E. Mavrakos, M.D. Iafrati, S.E. Doleman, M. Klagsbrun, Growth factors in bone matrix. Isolation of multiple types with affinity chromatography and heparin sepharose, J. Biol. Chem. 261 (1986) 12665-12674.
42. P.V. Hauschka, Growth factor effects in bone, in: B.K. Hall (Ed.), The Osteoblast and Osteocyte, The Telfor Press, Inc., 1990, pp. 103-170.
43. A.H. Reddi, Regulation of cartilage and bone differentiation by bone morphogenetic proteins, Curr. Opin. Cell Biol. 4 (1992) 850-855.
44. P.J. Boyne, R.E. Marx, M. Nevins, G. Triplett, E. Lazaro, L.C. Lilly, M. Alder, P. Nummikoski, A feasibility study evaluation rhBMP-2/absorbable collagen sponge for maxillary sinus augmentation, Int. J. Periodont. Restor. Dent. 17(1) (1997) 11-25.
45. E.J. Miller, R.K. Rhodes, Preparation and characterization of different types of collagen, Methods Enzymol. 82A (1982) 33-64.
46. S. Li, Collagen biotechnology and its medical applications, in: C.G. Gebelein (Ed.), Biotechnological Polymers: Medical, Pharmaceutical and Industrial Applications, 1993, pp. 66-81.
47. M.E. Bolander, G. Balian, The use of demineralized bone matrix in repair of segmental defects, J. Bone Jt. Surg. 68A (1986) 1264-1274.
48. R.W. Katz, J.O. Hollinger, A.H. Reddi, The functional equivalence of demineralized bone and tooth matrices in ectopic bone induction, J. Biomed. Mater. Res. 27 (1993) 239-245.
49. C.J. Damien, J.R. Parsons, A.B. Prewett, D.C. Rietveld, M.C. Zimmerman, Investigation of an organic delivery system for demineralized bone matrix in a delayed-healing cranial defect model, J. Biomed. Mater. Res. 28 (1994) 553-561.
50. H. Ohgushi, M. Okumura, S. Tamai, E.C. Shors, A.I. Caplan, Marrow cell-induced osteogenesis in porous hydroxyapatite and tricalcium phosphate: A comparative histomorphometric study of ectopic bone formation, J. Biomed. Mater. Res. 24 (1993) 1563-1570.
51. J.O. Hollinger, J.P. Schmitz, J.W. Mizgala, C. Hassler, An evaluation of two configurations of tricalcium phosphate for treating craniotomies, J. Biomed. Mater. Res. 23 (1989) 17-29.
52. P. Ducheyne, A. El-Ghannam, I. Shapiro, Effect of bioactive glass templates on osteoblast proliferation and in vitro synthesis of bone-like tissue, J. Cell. Biochem. 56 (1994) 162-167.
53. S.L. Stupp, G.W. Ciegler, Organoapatites: Materials for artificial bone. I: Synthesis and microstructure, J. Biomed. Mater. Res. 26 (1992) 169-183.
54. U. Ripamonti, S. Ma, A.H. Reddi, The critical role of geometry of porous hydroxyapatite delivery system in induction of bone by osteogenin, a bone morphogenetic protein, Matrix 12(3) (1992) 202-212.
55. S. Miyamoto, K. Takaoka, T. Okada, H. Yoshikawa, J. Hashimoto, S. Suzuki, K. Ono, Evaluation of polylactic acid homopolymers as carriers for bone morphogenetic protein, Clin. Orthop. 278 (1992) 274-285.
56. J.O. Hollinger, K. Leong, Poly(α-hydroxy acids): Carriers for bone morphogenetic proteins, Biomaterials 17 (1996) 187-194.
57. J.O. Hollinger, D. Jamiolkowski, S.W. Shalaby, Poly(α-hydroxy acids) and bone repair, in: J.O. Hollinger (Ed.), Biomedical Applications of Synthetic Biodegradable Polymers, CRC Press, Inc., Boca Raton, 1995.
58. M. Vert, S. Li, H. Garreau, New insights on the degradation of bio-resorbable polymeric devices based on lactic and glycolic acids, Clin. Mater. 10 (1992) 3-8.
59. A.G. Mikos, Y. Bao, L.G. Cima, D.E. Ingber, J.P. Vacanti, R. Langer, Preparation of poly(glycolic acid) bonded fiber structures for cell attachment and transplantation, J. Biomed. Mater. Res. 27 (1993) 183-189.
60. S.C. Lee, M. Shea, M.A. Battle, K. Kozitza, E. Ron, T. Turek, R.G. Schaub, W.C. Hayes, Healing of large segmental defects in rat femurs is aided by rhBMP-2 in PLGA matrix, J. Biomed. Mater. Res. 28 (1994) 1149-1156.
61. P.A. Lucas, C. Laurencin, G.T. Syftestad, A. Domb, V.M. Goldberg, A.I. Caplan, R. Langer, Ectopic induction of cartilage and bone by water soluble proteins from bovine bone using a polyanhydride delivery vehicle, J. Biomed. Mater. Res. 24 (1990) 901-911.
62. M. Richards, B.I. Dahiyat, D.M. Arm, P.R. Brown, K.W. Leong, Evaluation of polyphosphates and polyphosphonates as degradable biomaterials, J. Biomed. Mater. Res. 25 (1991) 1151-1167.
63. O.N. Tretinnikov, K. Kato, Y. Ikada, In vitro hydroxyapatite deposition onto a film surface grafted with organophosphate film, J. Biomed. Mater. Res. 28 (1994) 1365-1373.
64. M.L. Renier, D.H. Kohn, Development and characterization of a biodegradable polyphosphate, J. Biomed. Mater. Res. 34 (1997) 95-104.
65. C.T. Laurencin, M.E. Norman, H.M. Elgendy, S.F. El-Amin, S. Pucher, A. Ambrosio, H.R. Alcock, Polyphosphozanes-a novel biocompatible bioerodible polymer for bone regeneration, Trans. Orthop. Res. Soc. 18 (1993) 480.
66. T.A. Lindholm, T.J. Gao, Functional carriers for bone morphogenetic proteins, Ann. Chir. Gynaecol. 82 (1993) 3-12.
67. T. Sigurdssan, M.B. Lee, K. Kubota, T.J. Turek, J.M. Wozney, U.M.E. Wikesjo, Periodontal repair in dogs: Recombinant human bone morphogenetic protein-2 significantly enhances periodontal regeneration, J. Periodont. 66 (1995) 131-138.
68. T.J. Sigurdsson, L. Nygaard, D.N. Tatakis, E. Fu, T.J. Turek, L. Jin, J.M. Wozney, U.M.E. Wikesjo, Periodontal repair in dogs: Evaluation of rhBMP-2 carriers, Int. J. Periodont. Rest. Dent. 16 (1996) 525-537.
69. S. Gunesekeran, I.C. Bathurst, B. Constantz, J. Quiaoit, J. Ross, P.J. Barr, D. Gospodarowitz, Comparative utility of mineralized collagens as an osteoinductive material, in: P.W. Brown, B. Constanz (Eds.), Hydroxyapatite and Related Materials, CRC Press, Boca Raton, FL, 1994, pp. 171-180.
70. E.H. Riley, J.M. Lane, M.R. Urist, K.M. Lyons, J.R. Lieberman, Bone morphogenetic protein-2: Biology and applications, Clin. Orthop. Relat. Res. 324 (1996) 39-46.
71. U. Ripamonti, N. Duneas, Tissue engineering of bone by osteoinductive biomaterials, MRS Bull. 11 (1996) 36-39.
72. T.K. Sampath, A.H. Reddi, Dissociative extraction and reconstitution of extracellular matrix components involved in local bone differentiation, Proc. Natl. Acad. Sci. USA 78 (1981) 7599-7603.
73. D.M. Toriumi, W.F.J. Larrabee, J.W. Walike, D.J. Millay, D.W. Eisele, Demineralized bone. Implant resorption with long-term follow-up, Arch. Otolaryngol. Head Neck Surg. 116 (1990) 676-680.
74. A.W. Yasko, J.M. Lane, E.J. Fellinger, V. Rosen, J.M. Wozney, E.A. Wang, The healing of segmental bone defects induced by recombinant human bone morphogenetic protein (rhBMP-2), J. Bone Jt. Surg. Ser. A 74 (1992) 659-671.
75. L.J. Marden, J.O. Hollinger, A. Chaudhari, T. Turek, R. Schaub, E. Ron, Recombinant bone morphogenetic protein-2 is superior to demineralized bone matrix in repairing craniotomy defects in rat, J. Biomed. Mater. Res. 28 (1994) 1127-1138.
76. M. Nevins, C. Kirker-Head, M. Nevins, J.A. Wozney, R. Palmer, D. Graham, Bone formation in the goat maxillary sinus induced by absorbable collagen sponge implants impregnated with recombinant human bone morphogenetic protein-2, Int. J. Periodont. Rest. Dent. 16 (1996) 9-19.
77. C.A. Kirker-Head, T.N. Gerhart, S.H. Schelling, G.E. Hennig, E. Wang, M.E. Holtrop, Long-term healing of bone using human bone morphogenetic protein 2, Clin. Orthop. Relat. Res. 318 (1996) 222-230.
78. V.M. Paralkar, A.K.N. Nandedkar, R.H. Pointer, H.K. Kleinman, A.H. Reddi, Interaction of osteogenin, a heparin binding bone morphogenetic protein, with type IV collagen, J. Biol. Chem. 265 (1990) 17281-17284.
79. C.Q. Lin, M.J. Bissel, Multi-faceted regulation of cell differentiation by extracellular matrix, FASEB J. 7 (1993) 737-743.
80. J.O. Hollinger, G.C. Battistone, Biodegradable bone repair materials. Synthetic polymers and ceramics, Clin. Orthop. Relat. Res. 207 (1986) 290-305.
81. J.O. Hollinger, Factors for osseous repair and delivery: Part II, J. Craniofac. Surg. 4 (1993) 135-141.
82. E. Ron, R. Langer, Erodible systems, in: A. Kydonieus (Ed.), Treatise on Controlled Drug Delivery. Fundamentals, Optimization, Applications, Marcel Dekker, New York, 1992, pp. 199-224.
83. B.B. Brandt, G.M. Waters, M.J. Rispler, E.S. Kline, D- and L-lactate catabolism to carbon dioxide in rat tissues, Proc. Soc. Exp. Biol. Med. 175 (1984) 328-335.
84. J. Black, Biological Performance of Materials. Fundamentals of Biocompatibility, 2nd ed., Marcel Dekker, New York, 1992, pp. 1-390.
85. A.U. Daniels, M.S. Taylor, K.P. Andriano, J. Heller, Toxicity of absorbable polymers proposed for fracture fixation devices, Trans. Orthop. Res. Soc. 17 (1992) 88.
86. M.H. Mayer, J.O. Hollinger, Biodegradable bone fixation devices, in: J.O. Hollinger (Ed.), Biomedical Applications of Synthetic Biodegradable Polymers, CRC Press, Boca Raton, FL, 1995.
87. H. Winet, J.O. Hollinger, Incorporation of polylactide-polyglycolide in a cortical defect: Neoostegenesis in a bone chamber, J. Biomed. Mater. Res. 27 (1993) 667-676.
88. J. Nieuwenhuis, Synthesis of polylactides, polyglycolides and their copolymers, Clin. Mater. 10 (1992) 59-67.
89. E.L. Eliel, Stereochemistry of Carbon Compounds, McGraw-Hill, New York, 1962, pp. 1-128.
90. J. Brekke, A rationale for delivery of osteoinductive proteins, Tissue Eng. 2 (1996) 97-114.
91. J. Suganuma, H. Alexander, Biological response of intramedullary bone to poly-L-lactic acid, J. Appl. Biomater. 4 (1993) 13-27.
92. S. Li, H. Garreua, M. Vert, Structure-property relationships in the case of the degradation of massive aliphatic poly(α-hydroxy-acids) in aqueous media. Part 1: Poly(DL-lactic acid), J. Mater. Sci. Mater. Med. 1 (1990) 123-130.
93. J.O. Hollinger, J.P. Schmitz, D.E. Mark, A.E. Seyfer, Osseous wound healing with xenogeneic bone implants with a biodegradable carrier, Surgery 107 (1990) 50-54.
94. J.D. Heckman, B.D. Boyan, T.B. Aufdemorte, J.T. Abbott, The use of bone morphogenetic protein in the treatment of non-union in a canine model, J. Bone Jt. Surg. Ser. A 73 (1991) 751-763.
95. J. Kleinschmidt, J.O. Hollinger, N. Quigley, L.J. Marden, A multiphase system implant for regenerating calvaria, J. Plast. Reconstr. Surg. 91 (1993) 581-588.
96. J. Klawitter, S. Hulbert, Application of porous ceramics for the attachment of load bearing internal orthopedic applications, J. Biomed. Res. Symp. 2(1) (1971) 161-229.
97. J. Klawitter, J. Bagwell, A. Weinstein, B. Sauer, J. Pruitt, An evaluation of bone ingrowth into porous high density polyethylene, J. Biomed. Mater. Res. 10 (1976) 311-323.
98. M. Spector, S. Harmon, A. Kreutner, Characteristics of tissue ingrowth into porous proplast and porous polyethylene implants in bone, J. Biomed. Mater. Res. 13 (1979) 677-692.
99. R.E. Holmes, R.W. Bucholz, V. Mooney, Porous hydroxyapatite as a bone-graft substitute in metaphyseal defects, J. Bone Jt. Surg. Ser. A 68 (1986) 904-911.
100. B. Robinson, J.O. Hollinger, E. Szachowicz, J.H. Brekke, Calvarial bone repair with porous poly(D,L-lactide), Otolaryngol. Head Neck Surg. 112(6) (1995) 707-713.
101. R. Kenley, L. Marden, T. Turek, L. Jin, E. Ron, J. Hollinger, Osseous regeneration in the rat calvarium using novel delivery systems for recombinant bone morphogenetic protein 2 (rhBMP-2), J. Biomed. Mater. Res. 28 (1994) 1139-1147.
102. S. Ma, G. Chen, H. Reddi, Collaboration between collagenous matrix and osteogenin is required for bone induction, Ann. NY Acad. Sci. 580 (1990) 524-525.
103. J.L. Smith, L. Jin, T. Parsons, T. Turek, E. Ron, C.M. Philbrook, R.A. Kenley, L. Marden, J.O. Hollinger, M.P.G. Bostrom, E. Tomin, J.M. Lane, Osseous regeneration in preclinical models using bioabsorbable delivery technology for recombinant human bone morphogenetic protein 2 (rhBMP-2), J. Control. Release 36 (1995) 183-195.
104. J.O. Hollinger, M. Mayer, D. Buck, H. Zegzula, E. Ron, J. Smith, L. Jin, J. Wozney, Poly(α-hydroxy acid) carrier for delivering recombinant human bone morphogenetic protein-2 for bone regeneration, J. Control. Release 39 (1996) 287-304.
105. M. Mayer, J. Hollinger, E. Ron, J. Wozney, Maxillary cleft repair in dogs using recombinant human bone morphogenetic protein-2 and a polymer carrier, Plast. Reconstr. Surg. 98(2) (1996) 247-259.
106. H.S. Sandhu, L.E.A. Kanim, J.M. Kabo, J.M. Toth, E.N. Zeegen, D. Liu, R.B. Delamarter, E.G. Dawson, Effective doses of recombinant human bone morphogenetic protein-2 in experimental spinal fusion, Spine 21(18) (1996) 2115-2122.
107. H.S. Sandhu, L.E.A. Kanim, J.M. Kabo, J.M. Toth, E.N. Zeegen, D. Liu, L.L. Seeger, E.G. Dawson, Evaluation of rhBMP-2 with an OPLA carrier in a canine posterolateral (transverse process) spinal fusion model, Spine 20(24) (1995) 2669-2682.
108. A.L. Boskey, Osteopontin and related phosphorylated sialoproteins: Effects on mineralization, Ann. NY Acad. Sci. 760 (1995) 249-256.
109. T.K. Sampath, A.H. Reddi, Homology of bone inductive proteins from human, monkey, bovine and rat extracellular matrix, Proc. Natl. Acad. Sci. USA 80 (1983) 6591-6595.
110. J.F. Cavallaro, P.D. Kemp, K.H. Kraus, Collagen fabrics as biomaterials, Biotechnol. Bioeng. 43 (1984) 781-791.
111. E. Khor, Methods for the treatment of collagenous tissues for bioprostheses, Biomaterials 18 (1997) 95-105.
112. K.P. Rao, Recent developments of collagen-based materials for medical applications and drug delivery systems, J. Biomater. Sci. Polym. Ed. 7 (1995) 623-645.
113. X.J. Li, D. Toriumi, T.J. Turek, H. Seeherman, C. Francois, D. Desai, K. OGrady, J.M. Wozney, Healing of a canine critical-sized mandibular defect with an rhBMP-2/collagen implant involves de novo bone formation without chondrogenesis (abstract), J. Bone Miner. Res. (Suppl. 1) 11 (1996) S379.
114. T.F. Zioncheck, S.A. Chen, L. Richardson, M. Mora-Worms, C. Lucas, D. Lewis, J.D. Green, J. Mordenti, Pharmacokinetics and tissue distribution of recombinant human transforming growth factor beta-1 after topical and intravenous administration in male rats, Pharm. Res. 11 (1994) 213-220.
115. H. Uludag, G. Timony, D. Augusta, C. Blake, R. Palmer, K. Hammaerstone, J. Wozney, In vivo delivery of rhBMP-2 using collgen sponges (abstract), Trans. Control. Release Soc. 23 (1996) 51-52.
116. R.A. Kenley, K. Yim, J. Abrams, E. Ron, T. Turek, L.J. Marden, J.O. Hollinger, Biotechnology and bone graft substitutes, Pharm. Res. 10 (1993) 1393-1401.
117. D. Augusta, H. Uludag, G. Timony, C. Blake, R. Palmer, J. Golden, J. Li, S. Rathore, T. Porter, J. Wozney, In vivo retention of rhBMP-2 in biomaterial carriers (abstract), Pharm. Res. 13 (1996) S107.
118. R. Ruppert, E. Hoffmann, W Sebald, Human bone morphogenetic protein-2 contains a heparin-binding site which modifies its biological activity, Eur. J. Biochem. 237 (1996) 295-302.
119. R.S. Thies, M. Bauduy, B.A. Ashton, L. Kutzberg, J.M. Wozney, Recombinant human bone morphogenetic protein-2 induces osteoblastic differentiation in W20-17 cells, Endocrinology 130 (1992) 1318-1324.
120. D.I. Israel, J. Nove, K.M. Kerns, I.K. Moutsatsos, R.J. Kaufman, Expression and characterization of bone morphogenetic protein-2 in Chinese hamster ovary cells, Growth Factors 7 (1992) 139-150.
121. S. Duggirala, R.C. Mehta, P.P. DeLuca, The evaluation of lyophilized polymer matrices for administrating recombinant human bone morphogenetic protein-2, Pharm. Dev. Tech. 1 (1996) 165-175.
122. Y. Kuboki, T. Saito, M. Murata, H. Takita, M. Mizuno, M. Inoue, N. Nagai, A.R. Poole, Two distinctive BMP-carriers induce zonal chondrogenesis and membranous ossification, respectively: Geometrical factors of matrices for cell-differentiation, Con. Tis. Res. 32 (1995) 219-226.
123. I.V. Yannas, Biologically active analogues of the extracellular matrix: Artificial skin and nerves, Angew. Chem. Int. Ed. Engl. 29 (1990) 20-35.
124. G.F. Muschler, S. Negami, A. Hyodo, D. Gaissner, K. Easley, H. Kambic, Evaluation of collagen ceramic composite graft materials in a spinal fusion model, Clin. Orthop. 328 (1996) 250-260.
125. J.P. Vacanti, C.A. Vacanti, The challenge of tissue engineering, in: R. Lanza, R. Langer, W. Chick (Eds.), Principles of Tissue Engineering, R.G. Landes Co., Austin, TX, 1997, pp. 1-5.
126. E.A. Wang, D.L. Isreal, D.P. Luxenberg, Bone morphogenetic protein-2 causes commitment and differentiation in C3H10T1/2 and 3T3 cells, Growth Factors 9 (1993) 57-71.
127. A.I. Caplan, S.P. Bruder, Cell and molecular engineering of bone regeneration, in: R. Lanza, R. Langer, W. Chick (Eds.), Principles of Tissue Engineering, R.G. Landes Co., Austin, TX, 1997, pp. 603-618.
128. H. Yoshikawa, W.J. Rettig, K. Takaoka, E. Alderman, B. Rup, V. Rosen, J. Wozney, J. Lane, A. Huvos, P. Garin-Chesa, Expression of bone morphogenetic proteins in human osteosarcoma. Immunohistochemical detection with monoclonal antibody, Cancer 73(1) (1994) 85-91.
129. P. Ravel, H.H.T. Hsu, D.J. Schneider, M.P. Sarras, K. Masuhara, L. Bonewald, H.C. Anderson, Expression of bone morphogenetic proteins by osteoinductive and non-osteoinductive human osteosarcoma cells, J. Dent. Res. 75(7) (1996) 1518-1523.
130. P.D. Delmas, L. Malaval, The proteins of bone, in: G.R. Mundy (Ed.), Physiology and Pharmacology of Bone, Springer, New York, 1993, pp. 673-724.
131. M.R. Urist, E. Dawson, Intertransverse process fusion with the aid of chemosterilized autolyzed antigen-extracted allogeneic bone, Clin. Orthop. 154 (1981) 97-113.
132. E.E. Johnson, M.R. Urist, G.A.M. Finerman, Bone morphogenetic protein augmentation grafting of resistant femoral nonunions: A preliminary report, Clin. Orthop. 230 (1988) 257-265.
133. E.E. Johnson, M.R. Urist, G.A.M. Finerman, Repair of segmental defects of the tibia with cancellous bone grafts augmented with human bone morphogenetic protein, Clin. Orthop. 236 (1988) 249-257.